Albemarle Corp

ALB remains in a Stage 3 distribution phase after decisively breaking the $117.50 support and trading below all major EMAs/SMAs in bearish alignment. The medium-term bias is bearish, while short-term conditions are neutral amid oversold RSI and price extension. Selling should be deferred into rallies into the 127–130 EMA/SMA resistance zone for rejection. The long-term downtrend remains intact below the declining 200DMA.

• ↑Q2 net sales $1.7B, +31% YoY, driven by 45% lithium demand growth.
• ↑Adjusted EBITDA $858M, 49% margin, >80% operating cash conversion.
• ↓Negative earnings yield and weak profitability factors pressuring margins.